leisure time -WSS

leisure time

author：fashion 2025-08-06 05:21:53 - browse：863

illustration of a colorful DNA strand, partly broken into pieces. -- health coverage from STAT — Adobe

BALTIMORE — An ambitious effort to cure HIV with CRISPR genome editing fell short in an early clinical trial, investigators announced Friday morning.

In the study, run by Excision BioTherapeutics, researchers tried to use the gene editing tool to address a chief reason HIV has been so hard to cure. While antiviral drugs can clear patients of replicating virus, HIV is able to worm its way into a patients’ own DNA in certain cells. If the patient ever stops taking medicines, those cells start pumping out HIV particles and the infection roars back.

Researchers hoped they could send CRISPR to those cells and, by cutting the HIV DNA lurking there at two spots, slice out the virus. In the Phase 1 trial, investigators administered the treatment to five patients. They then took three of them off conventional antiviral treatment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Will General Catalyst be the first of many hospital takeovers?

leisure time

WSS

The Sacklers, horror, and ‘The Fall of the House of Usher’

4 missing after record

FAMU bans football players from facility after release of rap video shot in team's locker room

4 missing after record

MoonLake credibility takes another hit with mid

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

explore

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

entertainment

Duchenne breakthrough therapy leaves behind pioneering families

Sophia Smith scores twice for US in in 3

Dobbs anniversary: the lost opportunity of abortion as health care

Diversify hospital leadership teams to protect BIPOC patient health

Cancer drug shortages should be causing more outrage

More doctors should go into startup world

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The Sacklers, horror, and ‘The Fall of the House of Usher’

The cancer drug shortage isn’t new — and neither are the solutions

FDA approves Recor Medical high blood pressure device

focus

A clever new way to fix Medicaid and graduate medical education

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

White House calls on federal agencies to crack down on AI abuses

FAMU bans football players from facility after release of rap video shot in team's locker room

White House calls on federal agencies to crack down on AI abuses

MoonLake credibility takes another hit with mid

leisure time

hotspot

leisure time

focus